Top View
- Vanguard Developed Markets Index Fund Annual Report December 31, 2020
- Morphosys and Immunogen Expand Existing Collaboration License of Hucal(R) for Target Research
- Munich Companies Listed on the Stock Exchange
- Annual Financial Statements (Hgb) 2011
- Royalty Pharma Morphosys Transaction Presentation
- Euro Stoxx® Size Premium Index
- Stoxx® Europe 600 Index
- (12) United States Patent (10) Patent No.: US 9,676,865 B2 Lewicki Et Al
- Morphosys Achieves Milestone in GPC Biotech Cancer Collaboration First Morphosys Antibody to Show Efficacy in Animal Models
- Separate Financial Statements of Morphosys AG As of December 31, 2017 (German GAAP)
- 2020 IFRS Annual Report
- Morphosys Achieves Second Milestone in GPC Biotech Collaboration
- Incyte and Morphosys Announce Three-Year Results from Phase 2 L-MIND Study of Tafasitamab in Combination with Lenalidomide for T
- Made in Germany Special Report
- Stoxx® Europe Total Market Index
- Euro Stoxx® International Exposure Index
- 1 Bekanntmachung in Bezug Auf Die Folgenden Long Bzw. Short Mini
- Morphosys Finanzbericht
- Changes in the Indices
- Annual Financial Statements of Morphosys AG As of December 31, 2015 (German GAAP)
- Annual Report 2017 Morphosys AG Annual Report Product Pipeline Morphosys’S Product Pipeline (March 8, 2018)
- Corporate Governance Präsentation Zukunftsgerichtete Aussagen
- Financial Statements of Morphosys AG As of December 31, 2019
- Financial Statements of Morphosys AG As of December 31, 2020
- Results FY 2019 and Outlook 2020
- 1 Bekanntmachung in Bezug Auf Die Folgenden Long Bzw. Short Mini Future Turbo Optionsscheine Der Goldman, Sachs & Co. Wertpa
- Stoxx® Europe 600 Health Care Index
- AGM 2021 Speech
- Historical Index Compositions of the Equity- and Strategy Indices
- City of Colorado Springs Cemetery Endowment Fund
- Annual Report 2010 Morphosys AG Antibodies for Life for Antibodies 2010 Report Annual Key Figures (IFRS) Product Pipeline
- Eurex Circular 035/12
- Euro Stoxx® Small Index
- 1 Bekanntmachung in Bezug Auf Die Folgenden Long Bzw. Short Mini
- FTSE Germany All Cap
- Making Improvements in Life Possible
- Morphosys to Complete Transformational Acquisition of Constellation Pharmaceuticals, Bolstering Its Position in Hematology-Oncology
- Trading Notice 0227
- Annual Financial Statements of Morphosys AG As of December 31, 2018 (German GAAP)
- Half-Year Report January – June 2020
- Tracker Quant Research - Investment Recommendation History Current As of 12/09/2018
- The Biotechnology Sector in Germany
- Proxy Voting Disclosure
- Euronext ® Eurozone 300
- Morphosys Reports Six Months 2004 Results Company Raises Revenue and Cash Guidance for 2004
- View Annual Report
- The Advisors' Inner Circle Fund Iii Pinebridge Dynamic
- Annual Report Annual Report 2020 Annual Report Our Clinical Pipeline
- Berenberg Usa Conference 2018